Flagship Harbor Advisors’s Novavax NVAX Stock Holding History

Flagship Harbor Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,843	Closed	-$32.5K	–	1681
2025 Q4	$32.5K	Buy	+4,843	New	+$36.5K	﹤0.01%	1182
2022 Q3	–	Sell	-4,602	Closed	-$237K	–	608
2022 Q2	$237K	Hold	4,602	–	–	0.03%	521
2022 Q1	$339K	Buy	4,602 +1,003	+28%	+$89.4K	0.03%	447
2021 Q4	$515K	Buy	+3,599	New	+$618K	0.05%	361
2020 Q4	–	Sell	-290	Closed	-$31K	–	1322
2020 Q3	$31K	Sell	290 -100	-26%	-$12.2K	﹤0.01%	1009
2020 Q2	$32K	Buy	390 +105	+37%	+$4.02K	﹤0.01%	981
2020 Q1	$4K	Buy	285 +235	+470%	+$1.99K	﹤0.01%	1475
2019 Q4	$0	Hold	50	–	–	﹤0.01%	1929
2019 Q3	$0	Hold	50	–	–	﹤0.01%	1928
2019 Q2	$0	Hold	50	–	–	﹤0.01%	1939
2019 Q1	$0	Hold	50	–	–	﹤0.01%	1917
2018 Q4	$1K	Hold	50	–	–	﹤0.01%	1755
2018 Q3	$2K	Hold	50	–	–	﹤0.01%	1920
2018 Q2	$1K	Buy	+50	New	+$1.69K	﹤0.01%	1955

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Flagship Harbor Advisors's NVAX Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Novavax (NVAX) in Q1 2026, closing a stake of 4,843 shares — an estimated $32.5K sold.

Flagship Harbor Advisors first reported a position in NVAX in Q2 2018 and held it in 14 quarters. The position peaked at $515K in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Flagship Harbor Advisors reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
Flagship Harbor Advisors sold 4,843 Novavax shares in Q1 2026, an estimated $32.5K.
Flagship Harbor Advisors first reported a position in Novavax in Q2 2018 and held it in 14 quarters.
Flagship Harbor Advisors's Novavax position peaked at $515K in Q4 2021.
258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.